Education
About Us
Working with TipRanks
Follow Us
National Health Investors (NHI)
NYSE:NHI
RESEARCH TOOLSreports
Total Valuation
National Health Investors has a market cap or net worth of $3.33B. The enterprise value is $4.29B.
Market Cap$3.33B
Enterprise Value$4.29B
Share Statistics
National Health Investors has 46.69M shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding46.69M
Owened by Insiders4.73%
Owened by Instutions8.33%
Financial Efficiency
National Health Investors’s return on equity (ROE) is 0.10 and return on invested capital (ROIC) is 8.49%.
Return on Equity (ROE)10.09%
Return on Assets (ROA)5.27%
Return on Invested Capital (ROIC)8.49%
Return on Capital Employed (ROCE)9.76%
Revenue Per Employee$11,220,933.333
Profits Per Employee$4,599,500
Employee Count30
Asset Turnover0.10
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of National Health Investors is 22.04. National Health Investors’s PEG ratio is 68.98.
PE Ratio22.04
PS Ratio11.82
PB Ratio2.22
Price to Fair Value2.22
Price to FCF14.62
Price to Operating Cash Flow14.62
PEG Ratio68.98
Income Statement
In the last 12 months, National Health Investors had revenue of $336.63M and earned $137.99M in profits. Earnings per share was $3.14.
Revenue$336.63M
Gross Profit$268.27M
Operating Income$169.94M
Pretax Income$136.59M
Net Income$137.99M
EBITDA271.96M
Earnings Per Share (EPS)3.14
Cash Flow
In the last 12 months, operating cash flow was $208.17M and capital expenditures -$7.58M, giving a free cash flow of $200.59M billion.
Operating Cash Flow$208.17M
Free Cash Flow$200.59M
Free Cash Flow per Share$4.30
Dividends & Yields
National Health Investors pays an annual dividend of $0.90, resulting in a dividend yield of 5.04%
Dividend Per Share$0.90
Dividend Yield5.04%
Payout Ratio115.26%
Free Cash Flow Yield6.84%
Earnings Yield4.54%
Stock Price Statistics
Beta0.53
52-Week Price Change27.53%
50-Day Moving Average70.77
200-Day Moving Average72.60
Relative Strength Index (RSI)59.72
Average Volume (3m)265.22K
Important Dates
National Health Investors upcoming earnings date is May 12, 2025, Before Open.
Last Earnings DateFeb 25, 2025
Next Earnings DateMay 12, 2025
Ex-Dividend DateMar 31, 2025
Financial Position
National Health Investors as a current ratio of 0.96, with Debt / Equity ratio of 0.84
Current Ratio0.96
Quick Ratio0.96
Debt to Market Cap0.38
Net Debt to EBITDA4.25
Interest Coverage Ratio3.83
Taxes
In the past 12 months, National Health Investors has paid -$639.00K in taxes.
Income Tax-$639.00K
Effective Tax Rate0.00%
Enterprise Valuation
National Health Investors EV to EBITDA ratio is 15.75, with an EV/FCF ratio of 20.02.
EV to Sales16.18
EV to EBITDA15.75
EV to Free Cash Flow20.02
EV to Operating Cash Flow20.02
Balance Sheet
National Health Investors has $24.29M in cash and marketable securities with $1.15B in debt, giving a net cash position of $1.12B billion.
Cash & Marketable Securities$24.29M
Total Debt$1.15B
Net Cash$1.12B
Net Cash Per Share$24.02
Tangible Book Value Per Share$31.59
Margins
Gross margin is 100.00%, with operating margin of 83.56%, and net profit margin of 53.63%.
Gross Margin100.00%
Operating Margin83.56%
Pretax Margin53.63%
Net Profit Margin53.63%
EBITDA Margin102.77%
EBIT Margin74.97%
Analyst Forecast
The average price target for National Health Investors is $81.50, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$81.50
Price Target Upside11.94%
Analyst ConsensusModerate Buy
Analyst Count4
Revenue Growth Forecast4.88%
EPS Growth Forecast0.41%